Latest Medtronic Stories
STOUGHTON, Mass., July 20, 2011 /PRNewswire/ -- STD Med, Inc., a worldwide manufacturer and innovator of medical devices located in Stoughton, Massachusetts, is pleased to announce that one of its internally incubated medical device technologies, Spirus Medical, Inc., has been successfully acquired by Olympus Corporation. Spirus Medical, with its proprietary "rotate to advance technology" for diagnosis and treatment of gastrointestinal (GI) disorders, is the second exit for the medical...
CHICAGO, July 11, 2011 /PRNewswire/ -- Zacks Equity Research highlights Altera Corp. (Nasdaq: ALTR) as the Bull of the Day and PetMed Express (Nasdaq: PETS) as the Bear of the Day. In addition, Zacks Equity Research provides analysis Medtronic (NYSE: MDT), Boston Scientific Corporation (NYSE: BSX) and St Jude Medical (NYSE: STJ). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) Full analysis of all these stocks is available at http://at.zacks.com/?id=2678. Here is a synopsis of...
SAN MATEO, Calif., June 27, 2011 /PRNewswire/ -- Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that it has completed dosing the first patient in Part B of the ongoing Phase I study. Part B involves dosing cenderitide with Medtronic's insulin pump technology. The trial is being conducted pursuant to Nile's previously announced collaboration with Medtronic and is the first clinical step towards...
CHICAGO, June 23, 2011 /PRNewswire/ -- Today, Zacks Equity Research discusses the Medical Devices industry, including: Medtronic Inc. (NYSE: MDT), Boston Scientific Corporation (NYSE: BSX) and St. Jude Medical (NYSE: STJ). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) A synopsis of today's Industry Outlook is presented below. The full article can be read at http://www.zacks.com/stock/news/55667/Medical+Devices+Stock+Outlook+-+June+2011 With a slew of new products, the Big Three...
VANCOUVER, British Columbia, May 27, 2011 /PRNewswire-Asia/ -- It is possible to increase your stock returns using insider trading as an indicator, Insiderslab.com released alerts for CBS, General Motors, Vertex, Medtronic, VistaPrint, & Aeropostale. Insiderslab.com suggests investors listening to what insiders are telling. It is pretty common to see company's buyback announcement reported in the press releases. The Company itself is as important as those traditional insiders. Based on...
DEARBORN, Mich., May 18, 2011 /PRNewswire/ --Ford researchers demonstrate a series of possible in-car health and wellness connectivity services and apps aimed at helping people with chronic illnesses or medical disorders such as diabetes, asthma or allergies manage their condition while on the goLeveraging Ford SYNC®, researchers developed glucose device connectivity and monitoring capability, location-based allergy and pollen reports and voice-controlled, cloud-based health management...
Extraction of the Sprint Fidelis lead (Medtronic) can be safely performed in an experienced large volume center, according to research presented at the 2011 Heart Rhythm Society (HRS) conference in San Francisco last week.The Sprint Fidelis lead has been associated with increased failure rate which resulted in the lead being removed from the market in 2007. However, even if the lead does not fail, physicians are tasked with the decision as to whether or not to prophylactically remove the...
MILPITAS, Calif., May 9, 2011 /PRNewswire/ -- LifeScan, Inc., makers of the top-selling OneTouch® Brand of Blood Glucose Monitoring Systems for people with diabetes, has fulfilled the terms of its exclusive, three-year agreement to provide Medtronic customers in the U.S. with the OneTouch® UltraLink® Blood Glucose Meter that wirelessly transmits glucose values to Medtronic MiniMed Paradigm®( )insulin pumps and Guardian®( )REAL-Time continuous glucose monitoring (CGM)...
SAN MATEO, Calif., May 3, 2011 /PRNewswire/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced dosing of the first patient in a Phase I clinical trial investigating the use of subcutaneous cenderitide. The trial is being conducted pursuant to Nile's previously announced collaboration with Medtronic and is the first clinical step towards developing cenderitide as a treatment for the post-acute...
INDIANAPOLIS and MINNEAPOLIS, April 26, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Medtronic, Inc. (NYSE: MDT) today announced they have entered into a collaboration to research and develop a new approach to treating Parkinson's disease that involves delivering a potential new medicine to the brain using an implantable drug delivery system. The goal of the collaboration is to develop a therapeutic approach for Parkinson's disease that combines the strengths of Lilly's...
